Xtant Medical to Participate in Upcoming Investor Conferences
Xtant Medical Holdings, Inc. (NYSE American: XTNT) announces participation in Jefferies London Healthcare Conference and 14th Annual Craig-Hallum Alpha Select Conference. President and CEO, Sean Browne, to present at Jefferies conference. Live webcast available on company website.
11/09/2023 - 04:44 PM
BELGRADE, Mont., Nov. 09, 2023 (GLOBE NEWSWIRE) -- Xtant Medical Holdings, Inc. (NYSE American: XTNT), a global medical technology company focused on surgical solutions for the treatment of spinal disorders, today announced that management will participate in two upcoming investor conferences:
Jefferies London Healthcare Conference – November 14-16
Sean Browne, President and CEO, will present on Thursday, November 16 at 11:00 AM GMT / 6:00 AM ET and participate in 1x1 meetings with institutional investors. A live webcast of the Jefferies presentation will be available on the Investors section of the Company’s website at www.xtantmedical.com . A replay of the webcast will be available following the conclusion of the presentation.
14 th Annual Craig-Hallum Alpha Select Conference – November 16
Stavros G. Vizirgianakis, Chairman, and Scott Neils, Chief Financial Officer will participate in 1x1 meetings with institutional investors in New York. About Xtant Medical Holdings, Inc.
Xtant Medical’s mission of honoring the gift of donation so that our patients can live as full and complete a life as possible, is the driving force behind our company. Xtant Medical Holdings, Inc. (www.xtantmedical.com ) is a global medical technology company focused on the design, development, and commercialization of a comprehensive portfolio of orthobiologics and spinal implant systems to facilitate spinal fusion in complex spine, deformity and degenerative procedures. Xtant people are dedicated and talented, operating with the highest integrity to serve our customers.
The symbols™ and ® denote trademarks and registered trademarks of Xtant Medical Holdings, Inc. or its affiliates, registered as indicated in the United States, and in other countries. All other trademarks and trade names referred to in this release are the property of their respective owners.
Investor Relations Contact
David Careydavid.carey@finnpartners.com
What is the company name and ticker symbol mentioned in the press release?
The company mentioned is Xtant Medical Holdings, Inc. and the ticker symbol is XTNT.
When will the Jefferies London Healthcare Conference take place?
The Jefferies London Healthcare Conference will take place from November 14-16.
Who will be presenting at the Jefferies conference?
Sean Browne, the President and CEO, will be presenting at the Jefferies conference.
Where can the live webcast of the Jefferies presentation be accessed?
The live webcast of the Jefferies presentation will be available on the Investors section of the Company’s website at www.xtantmedical.com.
Xtant Medical Holdings Inc
XTNT Rankings
#224 Ranked by Stock Gains
XTNT Stock Data
Industry
Biological Product (except Diagnostic) Manufacturing
Sector
Manufacturing
Tags
Health Technology, Medical Specialties, Manufacturing, Biological Product (except Diagnostic) Manufacturing
Country
US
City
Belgrade
About XTNT
xtant medical (nyse mkt: xtnt) develops, manufactures and markets regenerative medicine products and medical devices for domestic and international markets. xtant products serve the specialized needs of orthopedic and neurological surgeons, including orthobiologics for the promotion of bone healing, implants and instrumentation for the treatment of spinal disease, tissue grafts for the treatment of orthopedic disorders, and biologics to promote healing following cranial, and foot and ankle surgeries. with core competencies in both biologic and non-biologic surgical technologies, xtant can leverage its resources to successfully compete in global neurological and orthopedic surgery markets. for further information, please visit xtantmedical.com.
